Combination of etanercept and twice-weekly administration of cyclosporin in psoriasis unsatisfactorily controlled by etanercept monotherapy: A retrospective analysis

European Journal of Inflammation

Volumn 10, Issue 2, 2012, Pages 239-242

  Vena, G A ^a   Mastrandrea, V ^a   Battaglini, S ^a   Loconsole, F ^a   Buquicchio, R ^a   Cassano, N ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Anti TNF treatment; Combination therapy; Cyclosporin; Etanercept; Psoriasis

Indexed keywords

CYCLOSPORIN A; EFALIZUMAB; ETANERCEPT;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG TOLERABILITY; FEMALE; HUMAN; HYPERTENSIVE CRISIS; MAINTENANCE THERAPY; MALE; MONOTHERAPY; PSORIASIS; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 84867227332     PISSN: 1721727X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1721727X1201000210     Document Type: Article

References (14)

1. Warren RB, Brown BC, Lavery D, Ashcroft DM, Griffiths CE. Biologic therapies for psoriasis: practical experience in a U.K. tertiary referral centre. Br J Dermatol 2009; 160:162-9.
2. Driessen RJB, Boezeman JB, van de Kerkhof PCM, de Jong EM. Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome. Br J Dermatol 2009; 160:670-5.
3. Altomare G, Ayala F, Berardesca E, et al. Etanercept provides a more physiological approach in the treatment of psoriasis. Dermatol Ther 2008; 21(S):S1-14.
4. Bachmann F, Kokolakis G, Sterry W, Philipp S. Etanercept: overview of clinical experience in the treatment of psoriasis and psoriatic arthritis. Int J Clin Rheumatol 2011; 6:135-55.
5. van de Kerkhof PCM, Segaert S, Lahfa M, et al. Once weekly administration of etanercept 5,0 mg is efficacious and well tolerated in patients with moderate-to-severe plaque psoriasis: a randomized controlled trial with open-label extension. Br J Dermatol 2008; 159:1177-85.
6. Foley PA, Quirk C, Sullivan JR, et al. Combining etanercept with traditional agents in the treatment of psoriasis: a review of the clinical evidence. J Eur Acad Dermatol Venereol 2010; 24:1135-43.
7. Daly M, Alikhan A, Armstrong AW. Combination systemic therapies in psoriatic arthritis. J Dermatolog Treat 2011; 22:276-84.
8. Lee EJ, Shin MK, Kim NI. A clinical trial of combination therapy with etanercept and low dose cyclosporine for the treatment of refractory psoriasis. Ann Dermatol 2010; 22:138-42.
9. Atzeni F, Boccassini L, Antivalle M, Salaffi F, Sarzi-Puttini P. Etanercept plus ciclosporin versus etanercept plus methotrexate for maintaining clinical control over psoriatic arthritis: a randomized pilot study. Ann Rheum Dis 2011; 70:712-4.
10. D'Angelo S, Cutro MS, Lubrano E, et al. Combination therapy with ciclosporin and etanercept in patients with psoriatic arthritis. Ann Rheum Dis 2010; 69:934-5.
11. Ioannides D, Mattheou-Vakali G, Lazaridou E, Batsios K, Panagiotidou D, Minas A. Maintenance treatment with cyclosporin in psoriasis. Br J Dermatol 1997; 136:470-1.
12. Thaçi D, Bräutigam M, Kaufmann R, Weidinger G, Paul C, Christophers E. Body-weight-independent dosing of cyclosporine micro-emulsion and three times weekly maintenance regimen in severe psoriasis. A randomized study. Dermatology 2002; 205:383-8. (Pubitemid 35356767)
13. Vena GA, Cassano N, Galluccio A, et al. Evaluation of the efficacy and tolerability of a new intermittent treatment regimen with cyclosporin A in severe psoriasis. G Ital Dermatol Venereol 2005; 140:575-82. (Pubitemid 43942772)
14. Colombo D, Cassano N, Altomare G, Giannetti A, Vena GA. Psoriasis relapse evaluation with week-end cyclosporine A treatment: results of a randomized, double-blind, multicenter study. Int J Immunopathol Pharmacol 2010; 23:1143-52.